Objective vestibular assessment, wherever care happens.
SmartVertigo™ brings portable eye-movement capture and documentation to military installations and VA facilities where a fixed vestibular lab will never exist.
From point of injury to long-term care.
Blast exposures, traumatic brain injuries, and high-G operations drive vestibular and balance issues among service members — and a long tail of post-deployment dizziness for the VA to manage.
Our clinical-grade wearable is designed to deliver portable, objective eye-movement capture and documentation in forward and resource-limited environments, and across the VA continuum of care.
- Deployable alongside combat medics in austere settings.
- Extends documentation to VA facilities managing post-deployment sequelae.
- No specialist on site required — reproducible, documented results every time.
Expanding vestibular access across the care continuum.
Post-deployment dizziness frequently presents at VA primary care, PT, audiology, and polytrauma clinics — often years later. SmartVertigo™ extends capture and documentation beyond the specialist, where Veterans already present.
- Polytrauma & TBI clinics — track vestibular signs longitudinally across rehabilitation.
- VA primary care — document dizziness at the first visit rather than routing every patient onward.
- Rural & CBOC sites — bring oculomotor-grade capture where no vestibular lab exists.
Built for federal acquisition pathways.
Designed from the outset for the regulatory, security, and procurement requirements of DoD and VA environments, with enterprise licensing for site- and system-wide deployment.
Designed for federal deployment
- FDA 510(k) clearance in process
- HIPAA-aligned data handling and audit trail
- Enterprise SaaS licensing across multiple installations
- Single-operator form factor — no specialty technician required
- Off-grid capture; reports sync when connectivity returns
- Designed to fit VA Computerized Patient Record System workflows
What we’ll need from you
- Procurement vehicle (GSA schedule, BPA, or direct award)
- Information assurance and ATO documentation requirements
- Site count, patient-volume estimates, and clinical contacts
- Integration scope (CPRS / VistA / commercial EHR)
- Training plan for clinical end-users at each site
SmartVertigo™ is currently under FDA review and has not yet received FDA clearance. It is intended to support documentation and clinician judgement, and for use only where permitted by applicable laws and regulations.
Bring the vestibular lab to your point of care.
Request a demo, ask a clinical question, or explore enterprise and federal licensing. Our team responds within one business day.